New York Life Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1K Buy
+4
New +$932 0.05% 192
2016
Q4
Sell
-130
Closed -$30K 258
2016
Q3
$30K Sell
130
-85
-40% -$20.8K 0.15% 162
2016
Q2
$50K Sell
215
-21
-9% -$4.84K 0.24% 135
2016
Q1
$63K Sell
236
-76
-24% -$21.8K 0.27% 123
2015
Q4
$98K Buy
312
+76
+32% +$22.6K 0.42% 95
2015
Q3
$64K Buy
236
+96
+69% +$29.5K 0.28% 127
2015
Q2
$42K Buy
+140
New +$41.8K 0.17% 153

Other funds holding AGN

New York Life Trust's AGN Position: Q1 2017 in Review

New York Life Trust opened a new position in Allergan plc (AGN) in Q1 2017: 4 shares worth $1K. The stake represents 0.05% of the portfolio and ranks #192 among its holdings. This is a return to the name: New York Life Trust previously reported a position in AGN as recently as Q3 2016.

New York Life Trust first reported a position in AGN in Q2 2015 and has held it in 7 quarters since. The position peaked at $98K in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • New York Life Trust held 4 shares of Allergan plc worth $1K as of Q1 2017.
  • Allergan plc was a new New York Life Trust position in Q1 2017.
  • Allergan plc made up 0.05% of New York Life Trust's portfolio in Q1 2017, its #192 holding.
  • New York Life Trust first reported a position in Allergan plc in Q2 2015 and has held it in 7 quarters since.
  • New York Life Trust's Allergan plc position peaked at $98K in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.